Skip to content
Riskpilot
← Back to search
Sign in
Get full access
KEIMON MEDICAL AS
AS
Active
Org 930009644
Kjøpmannsgata 40, 7011
Trondheim
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2022
0 employees
Watchlist
Share
Norway
/
Companies
/
Research and experimental development on natural sciences and engineering
/
KEIMON MEDICAL AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
1M
2025
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
-1M
2025
Income statement
NOK thousands
Item
2022
2023
2024
2025
Revenue
0
350
250
500
Staff expenses
−0
−0
−0
−0
EBITDA
−2
−56
−165
−920
Depreciation & amort.
−0
−0
−0
−872
EBIT
−2
−56
−165
−1 793
Net financials
0
−1
1
0
Profit before tax
−2
−57
−164
−1 793
Tax
−2
−12
−36
50
Net profit
0
−45
−128
−1 843
Balance sheet
NOK thousands
Item
2022
2023
2024
2025
Total assets
20
1 130
1 084
299
Equity
22
706
578
−1 265
Long-term debt
0
0
0
0
Short-term debt
−1
424
506
1 564
Total debt
−1
424
506
1 564
Financial ratios
5-year trend
EBITDA margin
-184.1%
This company
15.8%
Market median
-1265% vs market
2022
2025
Equity ratio
-423.1%
This company
38.2%
Market median
-1208% vs market
2022
2025
Return on equity
-184296200.0%
This company
18.4%
Market median
-1001609883% vs market
2022
2025
Net profit margin
-368.6%
This company
8.1%
Market median
-4651% vs market
2022
2025
Asset turnover
1.67×
This company
1.12×
Market median
+49% vs market
2022
2025
Debt / equity
1.24×
This company
0.62×
Market median
-100% vs market
2022
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-09-19 – 2022-12-31
View
PDF
More on KEIMON MEDICAL AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network